
Chemical and Pharmaceutical Bulletin p. 1468 - 1473 (1998)
Update date:2022-07-30
Topics:
Suzuki, Takeshi
Nagaoka, Hitoshi
Kondo, Yutaka
Takahashi, Takumi
Takeuchi, Makoto
Hara, Hiromu
Saito, Munetoshi
Yamada, Toshimitsu
Tomioka, Kenichi
Hamada, Mamoru
Mase, Toshiyasu
Conversion of the 2-(3-pyridyl)thiazolidine part of 1-(3-phenylpropyl)- 4-[2-(3-pyridyl)thiazolidine-4-carbonyl]piperazine (YM461), which is a potent platelet-activating factor (PAF) antagonist, to other rings was performed, and PAF antagonistic activitie
View MoreFeis International Trade Co,. Ltd
Contact:13961823444-18235944442
Address:Wuxi jiangsu
Zhushan County Tianxin Pharmaceutical & Chemical Co., Ltd.
Contact:0086-719-4224892
Address:Tutang Road, Chengguan Town, Zhushan County, Hubei Province
Chengdu ZY Biochemical Technology Co., LTD
Contact:0086-28-88680086
Address:170 Qingpu Road, Shouan Town, Pujiang County
Ji'nan Orgachem Pharmaceutical Co.,Ltd
Contact:+86-531-82687810
Address:Jinan
Contact:86-571-86737118-8689
Address:No.69, 12 Street, HEDA, Hangzhou, Zhejiang, China
Doi:10.1021/jo000210u
(2000)Doi:10.1021/ol000072v
(2000)Doi:10.1139/v70-348
(1970)Doi:10.1021/ja001958x
(2000)Doi:10.1002/1099-0682(200007)2000:7<1523::AID-EJIC1523>3.0.CO;2-2
(2000)Doi:10.1016/S0040-4039(01)87376-7
(1973)